Top Qs
Timeline
Chat
Perspective
Osaterone acetate
Chemical compound From Wikipedia, the free encyclopedia
Remove ads
Osaterone acetate, sold under the brand name Ypozane, is a medication which is used in veterinary medicine for the treatment of enlarged prostate in dogs.[3][5][6] It is given by mouth.[3]
Osaterone acetate is an antiandrogen, and hence is an antagonist of the androgen receptor, the biological target of androgens like testosterone and dihydrotestosterone.[3] It is also a progestin, or a synthetic progestogen, and hence is an agonist of the progesterone receptor, the biological target of progestogens like progesterone.[3]
Osaterone acetate was introduced for veterinary use in 2007.[1][3][7][8]
Remove ads
Uses
Veterinary
Osaterone acetate is used in veterinary medicine for the treatment of benign prostatic hyperplasia (BPH) in dogs.[3][5][6] It has been found to produce remission of clinical symptoms of BPH in 83% of dogs for six months after a single one-week course of treatment,[9] and can be used long-term.[6]
Available forms
Osaterone acetate comes in the form of 1.875 mg, 3.75 mg, 7.5 mg, and 15 mg oral tablets for veterinary use.[3]
Remove ads
Side effects
Side effects of osaterone acetate include diminished sperm quality (for up to 6 weeks post-treatment), transient elevation of liver enzymes (caution should be observed with known liver disease), vomiting, diarrhea, polyuria/polydipsia, lethargy, and hyperplasia of the mammary glands.[10] It can also decrease cortisol levels, interfere with adrenocorticotropic hormone response, induce or exacerbate adrenal insufficiency, and exacerbate diabetes mellitus.[11][10]
Remove ads
Pharmacology
Pharmacodynamics
Osaterone acetate is a steroidal antiandrogen, progestin, and antigonadotropin.[3] It has virtually no estrogenic or androgenic activity.[5] Its side-effect profile indicates that it possesses clinically relevant glucocorticoid activity.[11][10] An active metabolite of osaterone acetate, 15β-hydroxyosaterone acetate, has potent antiandrogenic activity similarly to osaterone acetate.[3] Osaterone acetate treats BPH in dogs by reducing the actions of androgens in the prostate gland.[3]
Pharmacokinetics
The major active metabolite of osaterone acetate is 15β-hydroxyosaterone acetate.[3] Osaterone acetate has a long biological half-life of 80 hours to 197 ± 109 hours in dogs.[3][4]
Chemistry
Osaterone acetate, also known as 2-oxachloromadinone acetate, as well as 17α-acetoxy-6-chloro-2-oxa-6-dehydroprogesterone or 17α-acetoxy-6-chloro-2-oxapregna-4,6-diene-3,20-dione, is a synthetic pregnane steroid and a derivative of progesterone and 17α-hydroxyprogesterone.[8] It is a derivative of the less potent chlormadinone acetate.[5] The medication is the C17α acetate ester of osaterone.[8]
Remove ads
History
Osaterone acetate was approved for veterinary use in the European Union under the brand name Ypozane in 2007.[1][3][7][8]
Society and culture
Generic names
Osaterone acetate is the generic name of the drug.[1][8] Osaterone is the INN of the deacetylated parent compound.[8]
Brand names
Osaterone acetate is marketed under the brand name Ypozane by Virbac throughout the European Union.[1][8]
Research
Osaterone acetate was also investigated in Japan in the treatment of prostate cancer and BPH in humans but was ultimately never marketed for such purposes.[5][12]
References
Further reading
Wikiwand - on
Seamless Wikipedia browsing. On steroids.
Remove ads